LIBERATE - PRO: Eclipse™ System Registry

NCT03028636 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 17

Last updated 2020-01-28

Study results available
· View outcomes & findings →

Summary

A prospective, open label post market registry to collect Patient Reported Outcomes in an online data capture registry, maintained by Pelvalon, of women with fecal incontinence exiting the LIBERATE study (NCT02428595) continuing to use the Eclipse System for bowel control.

Conditions

  • Fecal Incontinence
  • Bowel Dysfunction
  • Bowel Incontinence
  • Accidental Bowel Leakage

Sponsors & Collaborators

  • Pelvalon, Inc.

    lead INDUSTRY

Principal Investigators

  • Gena Dunivan, MD · Pelvalon Inc.; University of New Mexico

Eligibility

Min Age
19 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-19
Primary Completion
2019-02-27
Completion
2019-02-27

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03028636 on ClinicalTrials.gov